HLA Typing Market

The report "HLA Typing Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent), Application (Cancer research, infectious & Non infectious diseases, Transfusion therapy), End User (Hospital, Academia and Research) - Global Forecast to 2025", is projected to reach USD 1.7 billion by 2025 from USD 1.2 billion in 2019, at a CAGR of 5.9%. Growth in the HLA typing market is mainly driven by factors such as the increasing number of HLA typing procedures conducted, technological advancements in the field of HLA typing, and increasing funding for research.

Browse 158 market data Tables and 33 Figures spread through 185 Pages and in-depth TOC on "HLA Typing Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent), Application (Cancer research, infectious & Non infectious diseases, Transfusion therapy), End User (Hospital, Academia and Research) - Global Forecast to 2025"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/hla-typing-market-39129877.html

Reagents & consumables segment accounts for the largest share of the HLA typing market.

On the basis of product and service, the HLA typing market is segmented into reagents & consumables, instruments, and software & services. Reagents & consumables account for the largest share of the HLA typing market. The growing application horizons of molecular assay techniques in HLA typing, increasing patient emphasis on effective and early patient profiling during organ transplantation, the growing adoption of molecular diagnostic techniques in research studies, and the rising number of target procedures across major markets are driving the growth of this segment.

The molecular assay technologies segment accounted for the largest share of the HLA typing market in 2019.

On the basis of technology, the HLA typing market is segmented into molecular and non-molecular assay technologies. Molecular assay technologies held the largest market share, mainly due to their benefits over non-molecular assays—low turnaround times, high procedural efficacy, multi-sample study capabilities, and real-time sample analysis.

The diagnostic applications segment accounted for the largest share of the HLA typing market in 2019.

Based on application, the HLA typing market is segmented into diagnostic and research applications. The diagnostic applications segment dominated the HLA typing market. This is attributed to technological advancements in molecular assay techniques, the increasing adoption of molecular assay procedures for pathogen encounter detection and histocompatibility cross-matching, and the growing incidence of chronic and infectious diseases.

The commercial service providers segment accounted for the largest share of the HLA typing market in 2019.

On the basis of end user, the HLA typing market is segmented into commercial service providers, hospitals & surgical centers, and research laboratories & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the HLA typing market. This is attributed to their rapid modernization and adoption of automation, growing outsourcing of R&D activities to said providers, and the increasing consolidation of diagnostic laboratories.

North America to dominate the HLA typing market during the forecast period

The HLA typing market is segmented into five regional segments, namely, North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. The large share of North America can be attributed to the high adoption of advanced diagnostic technologies, increasing prevalence of target diseases in the US and Canada, and technological advancements. The rising geriatric population and growing funding and support for research are other major factors driving the growth of this regional segment.

The major players operating in the HLA typing market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Illumina, Inc. (US), Immucor, Inc. (US), CareDx (US), Becton, Dickinson and Company (US), Hologic (US), GenDx (Netherlands), and Biofortuna (UK), among others.

Don’t miss out on business opportunities in HLA Typing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]